Cargando…

Automated Detection of Patients at High Risk of Polypharmacy including Anticholinergic and Sedative Medications

Ensuring that medicines are prescribed safely is fundamental to the role of healthcare professionals who need to be vigilant about the risks associated with drugs and their interactions with other medicines (polypharmacy). One aspect of preventative healthcare is to use artificial intelligence to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirazibeheshti, Amirali, Ettefaghian, Alireza, Khanizadeh, Farbod, Wilson, George, Radwan, Tarek, Luca, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298435/ https://www.ncbi.nlm.nih.gov/pubmed/37372763 http://dx.doi.org/10.3390/ijerph20126178

Ejemplares similares

Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial
por: van der Meer, Helene G, et al.
Publicado: (2018)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications
por: Gadzhanova, Svetla, et al.
Publicado: (2015)

Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States
por: Cooperberg, Matthew R., et al.
Publicado: (2023)

Evaluation of the Effect of a Safe Medication Strategy on Potentially Inappropriate Medications, Polypharmacy and Anticholinergic Burden for People with Dementia: An Intervention Study
por: Kable, Ashley, et al.
Publicado: (2023)

Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
por: Jakeman, Bernadette, et al.
Publicado: (2022)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Anticholinergic and sedative medication use in older community‐dwelling people: A national population study in the Netherlands
por: van der Meer, Helene G., et al.
Publicado: (2019)

Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy
por: Liu, Jiazhen, et al.
Publicado: (2018)

Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study
por: Moorey, Hannah C., et al.
Publicado: (2016)

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2019)

Anticholinergic and sedative drug burden in community-dwelling older people: a national database study
por: Byrne, Catherine J, et al.
Publicado: (2018)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study
por: Sumbul-Sekerci, Betul, et al.
Publicado: (2023)

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model
por: Dinh, Truc Sophia, et al.
Publicado: (2023)

Improving the management of type 2 diabetes through large-scale general practice: the role of a data-driven and technology-enabled education programme
por: Radwan, Tarek F, et al.
Publicado: (2021)

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan
por: Al-Azayzih, Ahmad, et al.
Publicado: (2023)

Cognitive Decline in Older Persons Initiating Anticholinergic Medications
por: Shah, Raj C., et al.
Publicado: (2013)

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

Anticholinergic and Sedative Drug Burden and Functional Recovery after Cerebrovascular Accident: A Retrospective Descriptive Study
por: Ogawa, Yukari, et al.
Publicado: (2020)

A cross-sectional assessment of the relationship between sedative medication and anticholinergic medication use and the movement behaviour of older adults living in residential aged care
por: Parfitt, Gaynor, et al.
Publicado: (2020)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies
por: Wouters, Hans, et al.
Publicado: (2016)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls
por: Rosso, Andrea, et al.
Publicado: (2020)

Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study
por: Fujita, Kenji, et al.
Publicado: (2023)

Anticholinergic therapy: A case-based approach
por: Robinson, Dudley, et al.
Publicado: (2019)

Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: a cross-sectional study in Australia
por: Lim, Renly, et al.
Publicado: (2019)

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
por: Ang, Mei San, et al.
Publicado: (2017)

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2023)

Anticholinergic Medication and Caries Status Predict Xerostomia under 65
por: Cheah, Hui Ling, et al.
Publicado: (2023)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Exposure to anticholinergic and sedative medication is associated with impaired functioning in older people with vertigo, dizziness and balance disorders—Results from the longitudinal multicenter study MobilE-TRA
por: Katzenberger, Benedict, et al.
Publicado: (2023)

The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007)

Anticholinergic Drugs in Nonallergic Rhinitis
por: Naclerio, Robert
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_f2m7nr7e99nc231sgnvselpte0